Paper3918124
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.
Levine JF and 7 others. J Infect Dis, 1985. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. Papers, record 3918124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Enterobacteriaceae | Major topic |
| Gram-Negative Bacteria | Major topic |
| Kanamycin | Major topic |
| Acetyltransferases | |
| Bacterial Infections | |
| Drug Resistance, Microbial | |
| Enterobacteriaceae Infections | |
| Humans | |
| New York | |
| Pseudomonas Infections | |
| Pseudomonas aeruginosa | |
| R Factors |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33574807 | Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33574807 | PubMed |
| 22346558 | Ciprofloxacin or imipenem use correlates with resistance in Pseudomonas aeruginosa. | Can J Infect Dis | 1998 | https://conductscience.org/library/papers/22346558 | PubMed |
| 20107089 | Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex. | J Clin Microbiol | 2010 | https://conductscience.org/library/papers/20107089 | PubMed |
| 17423932 | Blood cultures from calves and foals. | Can Vet J | 1992 | https://conductscience.org/library/papers/17423932 | PubMed |
| 16772381 | Upgrading antibiotic use within a class: tradeoff between resistance and treatment success. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16772381 | PubMed |
| 15233318 | Generalized additive model demonstrates fluoroquinolone use/resistance relationships for Staphylococcus aureus. | Eur J Epidemiol | 2004 | https://conductscience.org/library/papers/15233318 | PubMed |
| 3752978 | Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3752978 | PubMed |
| 3646180 | The elimination of gentamicin-resistant gram-negative bacteria in a newborn intensive care unit. | Infection | 1987 | https://conductscience.org/library/papers/3646180 | PubMed |
| 3521478 | Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3521478 | PubMed |
| 3300827 | Is antimicrobial resistance in hospital microorganisms related to antibiotic use? | Bull N Y Acad Med | 1987 | https://conductscience.org/library/papers/3300827 | PubMed |
| 3300825 | Bacterial resistance: exploring the facts and myths. | Bull N Y Acad Med | 1987 | https://conductscience.org/library/papers/3300825 | PubMed |
| 3215695 | An international study on the occurrence of multiresistant bacteria and aminoglycoside consumption patterns. | Infection | 1988 | https://conductscience.org/library/papers/3215695 | PubMed |
| 3134209 | Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium. | Eur J Clin Microbiol Infect Dis | 1988 | https://conductscience.org/library/papers/3134209 | PubMed |
| 3093226 | Bacterial resistance after in vitro exposure to amikacin and netilmicin. | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3093226 | PubMed |
| 3056258 | Heterogeneity of 6'-N-acetyltransferases of type 4 conferring resistance to amikacin and related aminoglycosides in members of the family Enterobacteriaceae. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3056258 | PubMed |
| 3021052 | Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3021052 | PubMed |
| 3015007 | Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3015007 | PubMed |
| 2942105 | Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/2942105 | PubMed |
| 2848445 | Transposon-mediated amikacin resistance in Klebsiella pneumoniae. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/2848445 | PubMed |
| 2848443 | Isolation, characterization, and cloning of a plasmid-borne gene encoding a phosphotransferase that confers high-level amikacin resistance in enteric bacilli. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/2848443 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3918124
GET https://conductscience.org/api/papers/v1/3918124/cited_by?page=2